Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2014 by San Antonio Military Medical Center
Sponsor:
Collaborators:
Genentech
Galena Biopharma, Inc.
Information provided by (Responsible Party):
Jarrod P. Holmes, MD, FACP, San Antonio Military Medical Center
ClinicalTrials.gov Identifier:
NCT01570036
First received: March 25, 2012
Last updated: May 19, 2014
Last verified: May 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2017
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)